Cadmium, active smoking and renal function deterioration in patients with type 2 diabetes

被引:11
|
作者
Oosterwijk, Milou M. [1 ]
Hagedoorn, Ilse J. M. [1 ]
Maatman, Ronald G. H. J. [2 ]
Bakker, Stephan J. L. [3 ]
Navis, Gerjan [3 ]
Laverman, Gozewijn D. [1 ,4 ]
机构
[1] Ziekenhuis Grp Twente, Dept Internal Med Nephrol, Zilvermeeuw 1, Almelo, Netherlands
[2] Medlon BV, Dept Clin Chem, Enschede, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Hanzepl 1, Groningen, Netherlands
[4] Univ Twente, Biomed Signals & Syst, Enschede, Netherlands
关键词
cadmium; kidney disease; lifestyle; smoking; type; 2; diabetes; BLOOD-PRESSURE CONTROL; CHRONIC KIDNEY-DISEASE; EXPOSURE; LEAD; NEPHROPATHY; TOXICITY; PROGRESSION; POPULATION;
D O I
10.1093/ndt/gfac270
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background Cadmium is an established nephrotoxin, present in cigarette smoke. We investigated the hazards of cadmium concentration and smoking status on renal function deterioration. We furthermore discerned whether the association of cadmium concentration with renal function deterioration is attributable to smoking status. Methods Prospective analyses were performed in data of 226 patients of the DIAbetes and LifEstyle Cohort Twente-1 (DIALECT). Cadmium concentrations were determined from EDTA whole-blood. Smoking status was determined via a self-administered questionnaire. Renal function deterioration was defined as need for renal replacement therapy or a persistent decline of >= 30% in estimated glomerular filtration rate from baseline for at least 3 months. Multivariable Cox regression models were performed to calculate hazard ratios (HRs) for the association between smoking status, cadmium concentration and renal function deterioration. Results Median (interquartile range) whole-blood cadmium was 2.9 (1.9-5.1) nmol/L. Active smokers had significantly higher cadmium [7.4 (3.3-11.7) nmol/L] compared with never smokers [2.6 (1.6-4.2) nmol/L] and former smokers [2.8 (1.8-4.8) nmol/L]. During median follow-up for 6 (4-8) years, renal function deterioration occurred in 60 persons (27%). Both cadmium and active smoking were associated with an increased hazard for renal function deterioration [HR 1.37, 95% confidence interval (95% CI) 1.06-1.78 and 3.77, 95% CI 1.72-8.29, respectively]. In a multivariable model with both smoking status and cadmium concentration included, active smokers have an increased risk for renal function deterioration (HR 3.00, 95% CI 1.22-7.40), while the association between cadmium and renal function deterioration lost statistical significance (HR 1.16, 95% CI 0.87-1.54). Conclusions Active smoking is associated with progressive kidney disease in type 2 diabetes. The association between cadmium concentration and renal function deterioration in large part determined by smoking status. Extensive assessment of smoking status may be useful in patients with type 2 diabetesat high risk of kidney damage.
引用
收藏
页码:876 / 883
页数:8
相关论文
共 50 条
  • [1] Renal function deterioration in adult patients with type-2 diabetes
    Bramlage, Peter
    Lanzinger, Stefanie
    Hess, Eva
    Fahrner, Simon
    Heyer, Christoph H. J.
    Friebe, Mathias
    Buschmann, Ivo
    Danne, Thomas
    Holl, Reinhard W.
    Seufert, Jochen
    BMC NEPHROLOGY, 2020, 21 (01)
  • [2] Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus
    Orth, SR
    Schroeder, T
    Ritz, E
    Ferrari, P
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (11) : 2414 - 2419
  • [3] Renal function deterioration in adult patients with type-2 diabetes
    Peter Bramlage
    Stefanie Lanzinger
    Eva Hess
    Simon Fahrner
    Christoph H. J. Heyer
    Mathias Friebe
    Ivo Buschmann
    Thomas Danne
    Reinhard W. Holl
    Jochen Seufert
    BMC Nephrology, 21
  • [4] Visit-to-visit variability in albuminuria predicts renal function deterioration in patients with type 2 diabetes
    Lin, Chih-Hung
    Lai, Ying-Chuen
    Chang, Tien-Jyun
    Jiang, Yi-Der
    Chang, Yi-Cheng
    Chuang, Lee-Ming
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (06) : 1021 - 1029
  • [5] Association of Renal Function and Statin Therapy with Lipoprotein(a) in Patients with Type 2 Diabetes
    Hiraishi, Chika
    Matsui, Sadako
    Kojima, Takai
    Sato, Ryo
    Ando, Kiyotaka
    Fujimoto, Kei
    Yoshida, Hiroshi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2024, 31 (01) : 81 - 89
  • [6] RENAL FUNCTION IS ASSOCIATED WITH CATARACT DEVELOPMENT IN PATIENTS WITH TYPE 2 DIABETES
    Tomic, Martina
    Vrabec, Romano
    Ljubic, Spomenka
    Bulum, Tomislav
    Prkacin, Ingrid
    Rahelic, Dario
    ACTA CLINICA CROATICA, 2021, 60 : 18 - 23
  • [7] Joint relationship between renal function and proteinuria on mortality of patients with type 2 diabetes: The Taichung Diabetes Study
    Lin, Cheng-Chieh
    Chen, Ching-Chu
    Kung, Pei-Tseng
    Li, Chia-Ing
    Yang, Sing-Yu
    Liu, Chiu-Shong
    Lin, Wen-Yuan
    Lee, Cheng-Chun
    Li, Tsai-Chung
    Kardia, Sharon L. R.
    CARDIOVASCULAR DIABETOLOGY, 2012, 11
  • [8] Cardiac Autonomic Neuropathy as a Predictor of Deterioration of the Renal Function in Normoalbuminuric, Normotensive Patients with Type 2 Diabetes Mellitus
    Kim, Yong Kyun
    Lee, Jung Eun
    Kim, Yoon Goo
    Kim, Dae Joong
    Oh, Ha-Young
    Yang, Chul Woo
    Kim, Kwang-Won
    Huh, Wooseong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 : S69 - S74
  • [9] Chronic renal failure in type 2 diabetes patients
    Praga Terente, Manuel
    MEDICINA CLINICA, 2010, 134 (08): : 353 - 354
  • [10] Cardiovascular outcome according to renal status in Finnish patients with type 2 diabetes
    Hellman, Tapio A.
    Skare, Ole-Christian
    Lee, Christopher
    Wagner, Uta
    Vikkula, Johanna
    Hallfors, Jenni
    Laatikainen, Outi
    Lassenius, Mariann I.
    Metsarinne, Kaj
    DIABETES EPIDEMIOLOGY AND MANAGEMENT, 2022, 8